Claudia García Zorba Earns NIH Fellowship to Advance Preeclampsia Research

Preeclampsia remains a leading cause of maternal and fetal illness and death, yet treatment options are limited. For Tulane University doctoral student Claudia García Zorba, that clinical need is driving research into a targeted therapeutic approach designed to improve placental function and maternal health while minimizing fetal exposure.

García Zorba, a fourth-year biomedical engineering student in the School of Science and Engineering, has earned an F31 predoctoral fellowship from the National Institutes of Health. The nationally competitive fellowship recognizes her potential as a researcher and supports her development toward a career connecting engineering innovation with clinical medicine.

“Ultimately, the goal is to improve placental function and maternal health while minimizing fetal exposure, with the potential to improve pregnancy outcomes,” García Zorba said. Her research brings together targeted drug delivery and imaging technology to investigate how potential treatments reach the placenta and affect its function.

Preeclampsia involves high blood pressure and signs of organ dysfunction, posing serious risks to both mother and baby. Medications can help manage the condition, but delivery of the baby and placenta remains the only definitive treatment, creating difficult decisions when the condition develops before a pregnancy has reached full term.

Working with Dr. Carolyn Bayer, associate professor of biomedical engineering, García Zorba is developing a platform that combines placental-targeted drug delivery, controlled activation and photoacoustic imaging. The innovation lies in bringing these capabilities together to investigate a potential treatment while monitoring its delivery and effects.

“My research aims to address this challenge by developing a targeted, image-guided therapeutic platform that combines placental-targeted drug delivery, controlled activation, and photoacoustic imaging to monitor drug delivery and treatment response,” García Zorba said. The work is being conducted in rat models of preeclampsia as she develops and evaluates the approach.

The platform uses nanodroplets, tiny carriers designed to transport a therapeutic drug to the placenta. Photoacoustic imaging combines light with ultrasound detection, providing a way to follow drug delivery and assess changes associated with treatment.

García Zorba is developing and characterizing those droplets, with plans to investigate treatment over time. She also proposes modifying the light-absorbing material within the droplets to make their imaging signal easier to distinguish from signals associated with blood and improve imaging deeper within the body.

Her broader doctoral research includes shear wave elastography, an ultrasound technique that measures tissue stiffness. By studying the placenta and kidneys, she is exploring whether those measurements could serve as indicators of preeclampsia, connecting questions about diagnosis with her work on potential treatments.

The NIH F31 marks an important milestone in her development as an investigator. The fellowship program is designed for promising doctoral students with the potential to become independent research scientists, providing individualized, mentored training as they conduct dissertation research.

Applications undergo NIH peer review that considers the candidate’s preparation and potential, the proposed research training plan, and the mentorship supporting it. For García Zorba, receiving the fellowship represents national recognition of her promise and an opportunity to strengthen the skills needed to lead future research.

Originally from Puerto Rico, García Zorba earned her undergraduate degree in biomedical engineering at the University of Rochester. At Tulane, she earned a master’s degree along the way to her doctorate while gaining experience in research, teaching, and grant preparation.

Dr. Bayer helped guide her through the fellowship application, sharing examples from previous proposals, and supporting the development of her research plan. Weekly meetings and regular lab writing sessions provide a structure for advancing her projects and preparing to communicate their results.

Teaching opportunities have also helped García Zorba explore the career she hopes to build. She has delivered lectures in Biomedical Signals and Systems and an anatomy course for biomedical engineering students, helped instruct high school students during summer programming, and participated in teaching development through Tulane’s CELT program.

Connections through her mentor have provided opportunities to shadow and learn more about medical training. As she prepares for her next steps, she sees research, patient care and education as connected parts of her future.

“My long-term goal is to become a physician-scientist, combining research, clinical medicine, and teaching to advance maternal-fetal health, biomedical imaging, and drug delivery,” García Zorba said. Her doctoral work is building the foundation for that goal, with a focus on developing technologies that could eventually expand options for patients facing a serious pregnancy complication.